14:00 - 15:30
350: Rejection
Oral session
Room: Farabeuf
Chair/s:
Peter Friend, Carmen Capito
14:00 - 14:20
WHAT IS NEW ABOUT DIAGNOSIS AND TREATMENT OF CELLULAR REJECTION?
Girish Gupte, United Kingdom
14:20 - 14:40
HUMORAL REJECTION AND DSA : DIAGNOSIS, MANAGEMENT, FOLLOW UP
Esther Ramos-Boluda, Spain
14:40 - 15:00
PATHOLOGY : LANDSCAPE WITH ANTIBODIES, VESSELS AND  OTHER PEOPLE
Marion Rabant, France
15:00 - 15:10
DISCUSSION
Acute Rejection Following Intestinal Transplantation in a Cohort of 442 Transplants Performed Over Nearly 25 Years: The University of Miami Experience
Ahmed Farag 1, 2, Thiago Beduschi 1, Jeffrey J Gaynor 1, Gennaro Selvaggi 1, Akin Tekin 1, Jennifer Garcia 1, Rodrigo Vianna 1
1 Miami Transplant Institute, University of Miami, Miami, Florida, USA, 2 Zagazig University School of Medicine, Zagazig, Egypt.
The impact of circulating DSA in visceral transplant recipients without histological evidence of rejection: How should we treat or not treat?
Masato Fujiki 1, Mohammed Osman 1, Hajime Matsushima 1, Hirak Pahari 1, Yasser Fouda 1, Raffaele Girlanda 1, Aiwen Zhang 2, Kareem Abu-Elmagd 1
1 Center of Gut Rehabilitation and Transplantation, Cleveland Clinic, 2 Allogen Lab, Cleveland Clinic
Post-Transplant Proliferative Disorder Following Intestine Transplantation: Contemporary Single Center Experience
Jason Hawksworth, Asha Zimmerman, Alexander Kroemer, Pejman Radkani, Juan Guerra, Khalid Khan, Nada Yazigi, Stuart Kaufman, Sukanya Subramanian, Hannah Sagedy, Thomas Fishbein, Cal Matsumoto
MedStar Georgetown Transplant Institute